Aloisine A

Modify Date: 2024-01-31 13:29:32

Aloisine A Structure
Aloisine A structure
Common Name Aloisine A
CAS Number 496864-16-5 Molecular Weight 267.32600
Density 1.227g/cm3 Boiling Point N/A
Molecular Formula C16H17N3O Melting Point 281-283ºC
MSDS N/A Flash Point N/A

 Use of Aloisine A


Aloisine A (RP107) is a a potent cyclin-dependent kinase (CDK) inhibitor with IC50s of 0.15 μM, 0.12 μM, 0.4 μM, 0.16 μM for CDK1/cyclin B, CDK2/cyclin A, CDK2/cyclin E, CDK5/p35, respectively. Aloisine A ininhibits GSK-3α (IC50=0.5 µM) and GSK-3β (IC50=1.5 µM). Aloisine A stimulates wild-type CFTR and mutated CFTR, with submicromolar affinity by a cAMP-independent mechanism. Aloisine A has the potential for CFTR-related diseases, including cystic fibrosis research[1][2].

 Names

Name 4-(7-butyl-1,5-dihydropyrrolo[2,3-b]pyrazin-6-ylidene)cyclohexa-2,5-dien-1-one
Synonym More Synonyms

 Aloisine A Biological Activity

Description Aloisine A (RP107) is a a potent cyclin-dependent kinase (CDK) inhibitor with IC50s of 0.15 μM, 0.12 μM, 0.4 μM, 0.16 μM for CDK1/cyclin B, CDK2/cyclin A, CDK2/cyclin E, CDK5/p35, respectively. Aloisine A ininhibits GSK-3α (IC50=0.5 µM) and GSK-3β (IC50=1.5 µM). Aloisine A stimulates wild-type CFTR and mutated CFTR, with submicromolar affinity by a cAMP-independent mechanism. Aloisine A has the potential for CFTR-related diseases, including cystic fibrosis research[1][2].
Related Catalog
Target

CDK1/cyclinB:0.15 μM (IC50)

CDK2/cyclinA:0.12 μM (IC50)

CDK2/cyclinE:0.4 μM (IC50)

CDK5/p35:0.16 μM (IC50)

GSK-3β:0.5 μM (IC50)

GSK-3α:1.5 μM (IC50)

JNK:3-10 μM (IC50)

ERK1:18 μM (IC50)

ERK2:22 μM (IC50)

In Vitro Aloisine A ininhibits erk1 (IC50=18 µM), erk2 (IC50=22 µM), c-Jun N-terminal kinase (JNK; IC50~3-10 µM). Aloisine A has no effect on protein kinase C α, β1, β2, γ, δ, ε, η, ξ (all IC50>100 µM)[1]. Aloisine A (0.1, 1, 10, 100 µM) completely blocks the proliferation of dividing NT2 cells (IC50=7 μM) and differentiated postmitotic neurons (hNT; IC50=10.5 μM), and very few cells actually die[1]. Aloisine A acts as a submicromolar activator of wild-type (WT)-CFTR [human airway epithelial Calu-3 and WT-CFTR-Chinese hamster ovary (CHO) cells], G551D-CFTR (G551D-CFTR-CHO cells), and F508del-CFTR (in temperature-corrected human airway epithelial F508del/F508del CF15 cells)[2].
References

[1]. Yvette Mettey, et al. Aloisines, a new family of CDK/GSK-3 inhibitors. SAR study, crystal structure in complex with CDK2, enzyme selectivity, and cellular effects. J Med Chem. 2003 Jan 16;46(2):222-36.

[2]. Sabrina Noel, et al. Discovery of pyrrolo[2,3-b]pyrazines derivatives as submicromolar affinity activators of wild type, G551D, and F508del cystic fibrosis transmembrane conductance regulator chloride channels. J Pharmacol Exp Ther. 2006 Oct;319(1):349-59.

 Chemical & Physical Properties

Density 1.227g/cm3
Melting Point 281-283ºC
Molecular Formula C16H17N3O
Molecular Weight 267.32600
Exact Mass 267.13700
PSA 61.80000
LogP 3.67310
Index of Refraction 1.655

 Safety Information

HS Code 2933990090

 Customs

HS Code 2933990090
Summary 2933990090. heterocyclic compounds with nitrogen hetero-atom(s) only. VAT:17.0%. Tax rebate rate:13.0%. . MFN tariff:6.5%. General tariff:20.0%

 Synonyms

1ung
RP107
Aloisine A RP107
ALOISINE A
ALH
4-(7-butyl-5H-pyrrolo[2,3-b]pyrazin-6-yl)phenol